• Notice of clarification to drug manufacturers and sponsors: Canadian-specific considerations in risk …
• Submitting risk management plans draft guidance document: Introduction
• Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program …
• Notice: Prescription Drug List (PDL): Nicotine Qualifier Clarification
• Notice to Stakeholders – Clarification of Requirements Under the Food and Drug …